Study Protocol - NIC-PD Version 1
SEEK ID: https://ldh.kks-marburg.imise.uni-leipzig.de/documents/6?version=1
Filename: NIC-PD Protocol Version V03 F _2011_10_31.pdf
Format: PDF document
Size: 884 KB
Export PNG
Download
Creators and SubmitterViews: 67 Downloads: 0
Created: 6th Dec 2024 at 13:20
TagsThis item has not yet been tagged.
AttributionsNone
Version History
Version 1 (earliest) Created 6th Dec 2024 at 13:20 by Gerrit zur Hausen
No revision comments
Related items
Trial Projects:
- Phosphodiesterase-5 inhibition in patients with heart failure with preserved ejection fraction and combined post- and pre-capillary pulmonary hypertension (PASSION)
- Lymphadenectomy in Ovarian Neoplasms (LION)
- Efficacy and safety of adjuvant immunoadsorption in pemphigus vulgaris and pemphigus foliaceus (IA-pem)
- A randomized, placebo-controlled, double-blind, multi-centre trial to assess the disease-modifying potential of transdermal nicotine in early Parkinson's disease in Germany and the USA
- A randomized multicenter study to compare the efficacy of additional tumor debulking surgery versus chemotherapy alone for recurrent platinum-sensitive ovarian cancer
- Efficacy and Safety of Pegylated-Proline-Interferon Alpha 2b (AOP2014) in Maintaining Deep Molecular Remissions in Patients with Chronic Myeloid Leukemia (CML) who Discontinue ABL-Kinase Inhibitor Therapy
Institutions: Philipps-University Marburg, Coordinating Center for Clinical Trials
https://orcid.org/0009-0009-8967-7299
Trial Projects:
- Phosphodiesterase-5 inhibition in patients with heart failure with preserved ejection fraction and combined post- and pre-capillary pulmonary hypertension (PASSION)
- Lymphadenectomy in Ovarian Neoplasms (LION)
- Efficacy and safety of adjuvant immunoadsorption in pemphigus vulgaris and pemphigus foliaceus (IA-pem)
- A randomized, placebo-controlled, double-blind, multi-centre trial to assess the disease-modifying potential of transdermal nicotine in early Parkinson's disease in Germany and the USA
- A randomized multicenter study to compare the efficacy of additional tumor debulking surgery versus chemotherapy alone for recurrent platinum-sensitive ovarian cancer
- Efficacy and Safety of Pegylated-Proline-Interferon Alpha 2b (AOP2014) in Maintaining Deep Molecular Remissions in Patients with Chronic Myeloid Leukemia (CML) who Discontinue ABL-Kinase Inhibitor Therapy
Web page: Not specified
Transatlantic, multi-center, placebo-controlled, randomized, double-blind clinical trial to demonstrate that transdermal nicotine treatment retards parkinson's disease progression as measured by change in total (part I, II, III) UPDRS score between baseline and after 52 weeks of study treatment plus two more months wash out (60 weeks).
Sponsor: Philipps-University Marburg
Public web page: Not specified
Start date: 17th Oct 2012
End date: 15th Sep 2016
